Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

ResearchIn-Press PreviewImmunologyOncology Free access | 10.1172/JCI142823

An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection

Cory A. Brennick,1 Mariam M. George,1 Marmar R. Moussa,1 Adam T. Hagymasi,1 Sahar Al Seesi,2 Tatiana V. Shcheglova,1 Ryan P. Englander,1 Grant L.J. Keller,3 Jeremy L. Balsbaugh,4 Brian M. Baker,5 Andrea Schietinger,6 Ion I. Mandoiu,7 and Pramod K. Srivastava1

1Department of Immunology, University of Connecticut School of Medicine, Farmington, United States of America

2Computer Science and Engineering, Smith College, Northampton, United States of America

3Department of Chemistry and Biochemistry and Harper Cancer Research Institu, University of Notre Dame, Notre Dame, United States of America

4Proteomics and Metabolomics Facility, University of Connecticut, Storrs, United States of America

5Department of Chemistry & Biochemistry, Notre Dame, Notre Dame, United States of America

6Immunology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America

7Department of Computer Science and Engineering, University of Connecticut, Storrs, United States of America

Find articles by Brennick, C. in: JCI | PubMed | Google Scholar |

1Department of Immunology, University of Connecticut School of Medicine, Farmington, United States of America

2Computer Science and Engineering, Smith College, Northampton, United States of America

3Department of Chemistry and Biochemistry and Harper Cancer Research Institu, University of Notre Dame, Notre Dame, United States of America

4Proteomics and Metabolomics Facility, University of Connecticut, Storrs, United States of America

5Department of Chemistry & Biochemistry, Notre Dame, Notre Dame, United States of America

6Immunology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America

7Department of Computer Science and Engineering, University of Connecticut, Storrs, United States of America

Find articles by George, M. in: JCI | PubMed | Google Scholar

1Department of Immunology, University of Connecticut School of Medicine, Farmington, United States of America

2Computer Science and Engineering, Smith College, Northampton, United States of America

3Department of Chemistry and Biochemistry and Harper Cancer Research Institu, University of Notre Dame, Notre Dame, United States of America

4Proteomics and Metabolomics Facility, University of Connecticut, Storrs, United States of America

5Department of Chemistry & Biochemistry, Notre Dame, Notre Dame, United States of America

6Immunology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America

7Department of Computer Science and Engineering, University of Connecticut, Storrs, United States of America

Find articles by Moussa, M. in: JCI | PubMed | Google Scholar |

1Department of Immunology, University of Connecticut School of Medicine, Farmington, United States of America

2Computer Science and Engineering, Smith College, Northampton, United States of America

3Department of Chemistry and Biochemistry and Harper Cancer Research Institu, University of Notre Dame, Notre Dame, United States of America

4Proteomics and Metabolomics Facility, University of Connecticut, Storrs, United States of America

5Department of Chemistry & Biochemistry, Notre Dame, Notre Dame, United States of America

6Immunology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America

7Department of Computer Science and Engineering, University of Connecticut, Storrs, United States of America

Find articles by Hagymasi, A. in: JCI | PubMed | Google Scholar

1Department of Immunology, University of Connecticut School of Medicine, Farmington, United States of America

2Computer Science and Engineering, Smith College, Northampton, United States of America

3Department of Chemistry and Biochemistry and Harper Cancer Research Institu, University of Notre Dame, Notre Dame, United States of America

4Proteomics and Metabolomics Facility, University of Connecticut, Storrs, United States of America

5Department of Chemistry & Biochemistry, Notre Dame, Notre Dame, United States of America

6Immunology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America

7Department of Computer Science and Engineering, University of Connecticut, Storrs, United States of America

Find articles by Al Seesi, S. in: JCI | PubMed | Google Scholar |

1Department of Immunology, University of Connecticut School of Medicine, Farmington, United States of America

2Computer Science and Engineering, Smith College, Northampton, United States of America

3Department of Chemistry and Biochemistry and Harper Cancer Research Institu, University of Notre Dame, Notre Dame, United States of America

4Proteomics and Metabolomics Facility, University of Connecticut, Storrs, United States of America

5Department of Chemistry & Biochemistry, Notre Dame, Notre Dame, United States of America

6Immunology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America

7Department of Computer Science and Engineering, University of Connecticut, Storrs, United States of America

Find articles by Shcheglova, T. in: JCI | PubMed | Google Scholar

1Department of Immunology, University of Connecticut School of Medicine, Farmington, United States of America

2Computer Science and Engineering, Smith College, Northampton, United States of America

3Department of Chemistry and Biochemistry and Harper Cancer Research Institu, University of Notre Dame, Notre Dame, United States of America

4Proteomics and Metabolomics Facility, University of Connecticut, Storrs, United States of America

5Department of Chemistry & Biochemistry, Notre Dame, Notre Dame, United States of America

6Immunology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America

7Department of Computer Science and Engineering, University of Connecticut, Storrs, United States of America

Find articles by Englander, R. in: JCI | PubMed | Google Scholar |

1Department of Immunology, University of Connecticut School of Medicine, Farmington, United States of America

2Computer Science and Engineering, Smith College, Northampton, United States of America

3Department of Chemistry and Biochemistry and Harper Cancer Research Institu, University of Notre Dame, Notre Dame, United States of America

4Proteomics and Metabolomics Facility, University of Connecticut, Storrs, United States of America

5Department of Chemistry & Biochemistry, Notre Dame, Notre Dame, United States of America

6Immunology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America

7Department of Computer Science and Engineering, University of Connecticut, Storrs, United States of America

Find articles by Keller, G. in: JCI | PubMed | Google Scholar |

1Department of Immunology, University of Connecticut School of Medicine, Farmington, United States of America

2Computer Science and Engineering, Smith College, Northampton, United States of America

3Department of Chemistry and Biochemistry and Harper Cancer Research Institu, University of Notre Dame, Notre Dame, United States of America

4Proteomics and Metabolomics Facility, University of Connecticut, Storrs, United States of America

5Department of Chemistry & Biochemistry, Notre Dame, Notre Dame, United States of America

6Immunology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America

7Department of Computer Science and Engineering, University of Connecticut, Storrs, United States of America

Find articles by Balsbaugh, J. in: JCI | PubMed | Google Scholar |

1Department of Immunology, University of Connecticut School of Medicine, Farmington, United States of America

2Computer Science and Engineering, Smith College, Northampton, United States of America

3Department of Chemistry and Biochemistry and Harper Cancer Research Institu, University of Notre Dame, Notre Dame, United States of America

4Proteomics and Metabolomics Facility, University of Connecticut, Storrs, United States of America

5Department of Chemistry & Biochemistry, Notre Dame, Notre Dame, United States of America

6Immunology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America

7Department of Computer Science and Engineering, University of Connecticut, Storrs, United States of America

Find articles by Baker, B. in: JCI | PubMed | Google Scholar |

1Department of Immunology, University of Connecticut School of Medicine, Farmington, United States of America

2Computer Science and Engineering, Smith College, Northampton, United States of America

3Department of Chemistry and Biochemistry and Harper Cancer Research Institu, University of Notre Dame, Notre Dame, United States of America

4Proteomics and Metabolomics Facility, University of Connecticut, Storrs, United States of America

5Department of Chemistry & Biochemistry, Notre Dame, Notre Dame, United States of America

6Immunology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America

7Department of Computer Science and Engineering, University of Connecticut, Storrs, United States of America

Find articles by Schietinger, A. in: JCI | PubMed | Google Scholar |

1Department of Immunology, University of Connecticut School of Medicine, Farmington, United States of America

2Computer Science and Engineering, Smith College, Northampton, United States of America

3Department of Chemistry and Biochemistry and Harper Cancer Research Institu, University of Notre Dame, Notre Dame, United States of America

4Proteomics and Metabolomics Facility, University of Connecticut, Storrs, United States of America

5Department of Chemistry & Biochemistry, Notre Dame, Notre Dame, United States of America

6Immunology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America

7Department of Computer Science and Engineering, University of Connecticut, Storrs, United States of America

Find articles by Mandoiu, I. in: JCI | PubMed | Google Scholar |

1Department of Immunology, University of Connecticut School of Medicine, Farmington, United States of America

2Computer Science and Engineering, Smith College, Northampton, United States of America

3Department of Chemistry and Biochemistry and Harper Cancer Research Institu, University of Notre Dame, Notre Dame, United States of America

4Proteomics and Metabolomics Facility, University of Connecticut, Storrs, United States of America

5Department of Chemistry & Biochemistry, Notre Dame, Notre Dame, United States of America

6Immunology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America

7Department of Computer Science and Engineering, University of Connecticut, Storrs, United States of America

Find articles by Srivastava, P. in: JCI | PubMed | Google Scholar |

Published December 15, 2020 - More info

J Clin Invest. https://doi.org/10.1172/JCI142823.
Copyright © 2020, American Society for Clinical Investigation
Published December 15, 2020 - Version history
View PDF
Abstract

Identification of neoepitopes that are effective in cancer therapy is a major challenge in creating cancer vaccines. Here, using an entirely unbiased approach, we queried all possible neoepitopes in a mouse cancer model and asked which of those are effective in mediating tumor rejection, and independently, in eliciting a measurable CD8 response. This analysis uncovered a large trove of effective anticancer neoepitopes which have strikingly different properties from conventional epitopes and suggested an algorithm to predict them. It also revealed that our current methods of prediction discard the overwhelming majority of true anticancer neoepitopes. These results from a single mouse model were validated in another, antigenically distinct mouse cancer model, and are consistent with data reported in human studies. Structural modeling showed how the MHC I-presented neoepitopes have an altered conformation, higher stability, or increased exposure to T cell receptors as compared to the un-mutated counterparts. T cells elicited by the active neoepitopes identified here demonstrated a stem-like early dysfunctional phenotype associated with effective responses against viruses and tumors of transgenic mice. These abundant anticancer neoepitopes, which have not been tested in human studies thus far, can be exploited for the generation of personalized human cancer vaccines.

Version history
  • Version 1 (December 15, 2020): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts